Yubo International Biotech Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.01458 million compared to USD 0.098303 million a year ago. Net loss was USD 0.238096 million compared to USD 0.336584 million a year ago.
For the nine months, sales was USD 0.037763 million compared to USD 0.912103 million a year ago. Net loss was USD 1.31 million compared to USD 1.15 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.